[1] Zhao H, Wei R, Wang L, Tian Q, Tao M, Ke J, Liu Y, Hou W, Zhang L, Yang J, Hong T (correspondent). Activation of glucagon-like peptide-1 receptor inhibits the growth of human pancreatic cancer cells and promotes their apoptosis. Journal of physiology, endocrine and metabolism. 20 14，306:e 143 1- 144 1。

[2] Wang L, Liu Y, Yang J, Zhao H, Ke J, Tian Q, Zhang L, Wen J, Wei R, Hong T(*** with correspondent). Liraglutide upregulates PC 1-mediated proinsulin processing in pancreatic β cells through PKA-dependent pathway. Endocrinology.2014, doi:10.1210/en.2014-1218.

[3] Liu Y, Wei R, Hong T (correspondent). Potential role and mechanism of gluton-like peptide-1 in nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014,20 (27): 9090-9097.

[4] Zhao H, Wang L, Wei R, Xiu D, Tao M, Ke Jie, Liu Y, Yang J, Hong T (correspondent). The activation of glucagon-like peptide-1 receptor inhibits the metastasis of human pancreatic cancer cells through PI3K/ Akt pathway. Diabetes is accompanied by metabolism. 20 14.doi: 10. 1 1 1 1/DOM

[5] Liu Y, Hong T (correspondent). Combination therapy of dipeptidyl peptidase -4 inhibitor and metformin in type 2 diabetes mellitus: principle and evidence. Diabetes mellitus Obes Metab20 14,16:11-17.

[6] Chen Y, Feng R, Wang H, Wei R, Yang J, Wang L, Wang H, Zhang L, Hong T (* * * the same correspondent), Wen J. Early onset diabetes induced by high-fat diet in heterozygous Pax6 mutant mice. Diabetes metabolism research version 20 14. doi: 10. 1002/dmrr . 2572。

[7] Gao M, Yang J, Wei R, Liu G, Zhang L, Wang H, Wang G, Gao H, Chen G, Hong T. Ghrelin induced human embryonic stem cells to differentiate into cardiac lineages through ERK 1/2 pathway, int j cardiol.20 13,160.

[8] Wei R, Yang J, Hou W, Liu G, Gao M, Zhang L, Wang H, Mao G, Gao H, Chen G, Hong T (correspondent). Comparison of insulin secreting cells derived from human embryonic stem cells based on endoderm and nestin positive progenitor cells. Plos One 20 13，8(8):e725 13。

[9] Wei R, Yang J, Liu, Gao MJ, Hou, Zhang L, Gao HW, Liu Y, Chen Ga, Hong TP (correspondent). Dynamic expression of microRNA during differentiation of human embryonic stem cells into insulin-secreting cells. Gene 2013,518 (2): 246-255.

[10] Xiao, Wang YR, Hou, Xie c, Wang, hong t, Gao H. Effect of pioglitazone on biochemical indexes of bone turnover in patients. Journal of Endocrinology 20 13, 20 13:290734.

[1 1] Wang G, He L, Liu J, Yu J, Feng X, Li F, Hao Y, Mao J, Hong T, Chen AF, Wang X .α agonist feno? Brate in hypertriglyceridemia patients. Cardiovascular therapy 2013,31(3):161-167.

[12] Gao M, Yang J, Liu G, Wei R, Zhang L, Wang H, Wang G, Gao H, Chen G, Hong T (correspondent). Ghrelin promotes the differentiation of human embryonic stem cells in invasive cardiac microenvironment. Peptide 2012,34 (2): 373-379.

[13] Heqh, Zhang Xiaoyan, Lu Al, Lan Fang, Hong TP (correspondent), Shen L. Combining PCR fragment sequencing with genotyping to diagnose Kennedy's disease. China Journal of Biochemistry and Molecular Biology 2012,28 (3): 283-288.

[14] Wang HL, Fan DS, Hong TP. Is the polymorphism of methylenetetrahydrofolate reductase gene C677T or plasma homocysteine a risk factor for diabetic peripheral neuropathy in China? Research on nerve regeneration 2012,7 (30): 2384-2391.

China Diabetes Association's Position Statement on Stem Cell Therapy for Diabetes. J Diabetes 2012,4 (1):18-21.

[16] Yang J, Liu, Wei R, Hou, Gao MJ, Zhu MX, Wang, Chen Ga, Hong TP (correspondent). Ghrelin promotes the differentiation of human embryonic stem cells into cardiomyocytes. Journal of Pharmacology 20 1 1, 32 (10):1239-1245.

[17] Liu Jun, Luc, Li Fu, Wang H, He L, Hao Y, Chen AF, An H, Wang X, Hong T (* * * same correspondent), Wang G .α agonist fenofibrate up-regulated the level of tetrahydrobiopterin by increasing the expression of guanosine triphosphate cyclohydrolase -i in human umbilical vein endothelial cells. PPAR resolutions 20 1 1, 20 1 1:523520

[18] Wang G, He L, Hong T. Reply to the editor's letter: Coronary blood flow velocity reserve in patients with chronic hyperhomocysteinemia is impaired: why? . Am J physiological endocrine metabolism 20 1 1, 300 (6): e1177-e1/78.

[19] Liu Z, Wang H, Xiao W, Wang C, Liu G and Hong T (correspondents). Interferon -g upregulates the expression of interleukin-18 in thyroid cells, which may contribute to the thyroid destruction of Hashimoto's thyroiditis. Int J Exp Pathol 20 10，9 1(5):420-425

[20] He Li, Ceng Hong, Feng Li, Feng Jun, Liu S, Liu Jun, Yu Jun, Mao Jun, Hong Tao, Chen Yafeng, Wang X, Wang G. Hyperhomocysteinemia patients damage coronary artery endothelial function by inhibiting tetrahydrobiopterin. American Journal of Physiology Endocrine Metabolism 20 10, 299 (6): E1061-1065.

[2 1] Wen, Chen, Song Shijun, Ding Jun, Gao Y, Hu, Feng RP, Liu Yongzhi, Ren GC, Zhang Chunyu, Hong TP (* * * with correspondent), Gao X, Li LS. Pairing box 6 (PAX6) regulates glucose metabolism through proinsulin processing mediated by prohormone convertase 1/3 (PC 1/3). Diabetes 2009,52 (3): 504-513.

[22] Gao H, Xiao W, Wang C, Zhang J, Yang Y, Yang J, Yang W, Hong T (correspondent). Metal effect of once-daily sustained-release prescription in patients with type 2 diabetes mellitus: a multicenter study. International Journal of Clinical Practice 2008,62 (5): 695-700.

[23] Wang, Wang YR, Liu, Liu Z, Wu PX, Wei XL, Hong TP (correspondent). Rosiglitazone inhibits the production of interleukin-18 in the liver of rats with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2008, 14 (47): 7240-7246.

[24] Gao HW, Xie Bing, Wang, Lin, Hong TP (correspondent). Compared with acarbose, nateglinide has beneficial metabolic effects on newly diagnosed patients with type 2 diabetes. Journal of Pharmacology 2007,28 (4): 534-539.

[25] Gao H, Wang C, Wang H, Yang X, Li J, Hong T (correspondent). Lipomas of penis and perineum in a 6-year-old boy. European Journal of Pediatrics 2005, 164 (2).

Zhang Lisheng, Hong Dongping (correspondent), Hu Jun, Liu, Wu, Li Lishan. Nestin-positive progenitor cells isolated from human fetal pancreas have the same phenotypic markers as mesenchymal stem cells. World Journal of Gastroenterology 2005,11(19): 2906-2911.

[27] Zhang Lilun, Hu Jun, Hong Tingping (correspondent), Liu Yongning, Yong-Hua Wu, Li Lishan. Monoclonal lateral group predictor isolated from human lethal pancreas. Journal of Biochemistry and Biophysics Society 2005,333 (2): 603-608.

[28] Hong TP, Andersen NA, Nielsen K, Karlsen AE, Fantuzzi G, Eizirik DL, Dinarello CA, Mandrup-Poulsen T. Interleukin-18 mRNA was constitutively expressed in islet β cells, and was up-regulated by IFN-γ, but IL-1. European cytokine network 2000,11(2):193-205.

Published more than 200 articles.

Main papers in recent 5 years:

[1] Hong Tianpei. Pay attention to the research progress of translational medicine in the new treatment of diabetes. China medical frontier journal (electronic edition), 2014,6 (1):1-3.

Hong Tianpei. The embodiment of translational medicine in the treatment of type 2 diabetes with insulin detemir. China Journal of Diabetes.2014,22 (3): 283-285.

Hou and Hong Tianpei (correspondent). Research progress in the treatment and prevention of type 2 diabetes by bariatric surgery. China medical frontier journal (electronic edition), 2014,6 (1):14-18.

Wang Chen, Gao Hongwei and Hong Tianpei (correspondents). New progress of artificial pancreas. China medical frontier journal (electronic edition), 2014,6 (1): 4-8.

Xiao Wenhua and Hong Tianpei (correspondents). Cardiovascular safety of drugs based on glucagon-like peptide 1. China medical frontier journal (electronic edition), 2014,6 (1):19-23.

Xie Chao and Hong Tianpei (correspondents). Pancreatic safety based on glucagon-like peptide 1. China medical frontier journal (electronic edition), 2014,6 (1): 24-28.

Jing Ke, Wei Rui, Hong Tianpei (correspondent), Liu Ye, Jin Yang, Tian Zi, Zhang Lin and Wang Guang. Metformin combined with liraglutide has synergistic protective effect on palmitic acid-induced oxidative damage of endothelial cells. China Journal of Diabetes.2014,6 (5): 312-33.

Li Jufen, Jing Ke, Jin Yang, Wei Rui and Hong Tianpei (correspondent). Effect of liraglutide on oxidative damage of endothelial cells induced by high glucose. China Journal of Diabetes. 20 14，22 (5): 455-458。

Wei Rui and Hong Tianpei (correspondents). Research progress of stem cell technology in endocrine and metabolic diseases. China Journal of Endocrinology and Metabolism. 20 14, 30(3):250-253.

[10] Jin Yang, Wei Rui and Hong Tianpei (correspondents). A new perspective on the pathogenesis of type 2 diabetes: dedifferentiation of islet β cells. China Journal of Diabetes. Accept.

[1 1], Hong Tianpei (correspondent), Gao Meijuan, Hou, Zhang Lin, Wang Haining,. Ghrelin promotes the directional differentiation of human embryonic stem cells into cardiomyocytes in a non-classical receptor-dependent way. China Journal of Diabetes. Roger that.

[12] Liu Guoqiang, Wei Rui and Hong Tianpei (correspondents). Research progress of stem cell transplantation for diabetes mellitus. China medical frontier journal.2014,6 (1): 9-13.

Gao Hongwei, Hong Tianpei (correspondent). Based on the position of glucagon-like peptide-1 in the treatment of type 2 diabetes. Journal of clinical medicine. 20 14, 12 ( 1): 4- 17.

Ma Shifeng, Hong Tianpei (correspondent), Wei Rui, Liu Ye, Jin Yang, Zhang Lin, Wang Guang. Protective effect of exenatide on homocysteine-induced oxidative damage of human umbilical vein endothelial cells and its mechanism. China Journal of Diabetes 2013,21(4): 65438.

An Huijie, Hong Tianpei (correspondent), Wang Guang, Wei Rui, Liu Ye, Jin Yang, Zhang Lin. Reversal effect of metformin on endothelial dysfunction induced by fluctuating high glucose and its mechanism. China Journal of Diabetes 2013,5 (4): 231-234.

[16] Wei Rui, Hong Tianpei (correspondent). Effects of vascular endothelial cells on the development and function of islets. World chinese journal of digestology 2013,21(25): 2493-2499.

Wei Rui, Hong Tianpei. Pay attention to the research progress on the correlation between obesity and diabetes and its potential mechanism. Chinese Journal of Medicine 2013,93 (36): 2849-2850.

[18] An Huijie, Wei Rui, Hong Tianpei (correspondent). Cardiovascular protection of metformin in patients with type 2 diabetes mellitus: evidence and its potential mechanism. China Journal of Endocrinology and Metabolism 2013,29 (9);

Liu Huilin, Tian Xian, Hong Tianpei (correspondent), Liu Guihua, Pan Huan, Wang Haining, Gao Hongwei. Deterioration of serum programmed cell death factor 5 level in patients with sepsis. Journal of Peking University (Medical Edition) 2013,45 (2): 238.

Hou, Tian Xian, Xiao Wenhua and Hong Tianpei (correspondents). Clinical reaction of Langerhans cell histiocytosis complicated with central diabetes insipidus and cervical spondylosis. China Journal of Endocrinology and Metabolism 2013,29 (6): 531-533.

Hou, Xiao Wenhua, Hong Tianpei (correspondent). Effect of thiazolidinediones on bone metabolism in patients with type 2 diabetes mellitus and its mechanism. China Journal of Diabetes 2013,22 (7): 666-668.

Liu Ye, Hong Tianpei, Zhu, Wang Haining. Research progress of radionuclide molecular imaging technology in islet β cell imaging. China Journal of Nuclear Medicine and Molecular Imaging 2013,33 (1): 74-78.

Liu Ye Hong Tianpei (correspondent). Efficacy and safety of dipeptidyl peptidase -4 inhibitor combined with metformin. China Journal of Diabetes 2013,5 (7): 437-440.

[24] Hong Tianpei. DPP-4 inhibitors have extensive benefits in treating patients with type 2 diabetes. Drug evaluation: 20 13,10 (11): 40-43.

[25] Tian Xian, Hong Tianpei (correspondent). Pathophysiology and treatment of insulin secretion dysfunction. China Journal of Diabetes 2012,20 (11): 872-874.

Tian Xian and Hong Tianpei (correspondents). Rationality of basal insulin combined with glucagon-like peptide-1 receptor agonist in the treatment of diabetes mellitus. China Journal of Diabetes 2012,4 (8): 500-502.

[27] Tian Xian, Gao Hongwei, Hong Tianpei. Significance and clinical significance of glycosylated hemoglobin detection. China Journal of Laboratory Medicine 2012,35 (6): 505-508.

Ma Shifeng, Wang Chen and Hong Tianpei (correspondents). Beneficial effects of glucagon-like peptide-1 and its analogues on vascular endothelial function. China Journal of Diabetes 2012,4 (9): 564-568.

[29] Liu Ye, Hong Tianpei (correspondent). Rationality and research evidence of DPP-4 inhibitor combined with metformin. China Journal of Endocrinology and Metabolism 2012,28 (12):1033-1038.

Hou, Wang Haining and Hong Tianpei (correspondents). Interleukin 18 and insulin resistance. China Journal of Diabetes 2012,20 (2):158-160.

[3 1] Hong Tianpei. Translational medicine research on endocrine and metabolic diseases. China Journal of Endocrinology and Metabolism 2012,28 (3):171-174.

Hong Tianpei. A new oral hypoglycemic agent DPP-4 inhibitor: New progress in the treatment of type 2 diabetes from islet α cells. China Journal of Diabetes 2012,20 (7): 558-560.

Zhao Hezhen, Wei Rui and Hong Tianpei (correspondents). Advances in microRNA and Pancreatic Development and Stem Cell Differentiation. World chinese journal of digestology 2012.20 (21):1913-1965438.

[34] Wang Liang, Zhao Hezhen, Wei Rui and Hong Tianpei (correspondents). Summary of the first forum on endocrinology, metabolism and translational medicine of Chinese Medical Association. China Journal of Endocrinology and Metabolism 20 12. 28(3):252-254.

Wei Rui and Hong Tianpei (correspondents). Research progress and application prospect of stem cell technology in treating diabetes. World chinese journal of digestology. 20 1 1. 19 (5): 44 1-450.

[36] Wang Xiaoxia, Ma Zhi, Hong Tianpei, Xu Yuan,,, Wang Haining. Performance evaluation of A 1cNOW+TM glycosylated hemoglobin detection card. China Journal of Diabetes 20 1 1, 19 (165438).

,, He,, Hao Yanting, Hong Tianpei (correspondent). Effect of abnormal glucose metabolism on coronary endothelial function in patients. Shandong medicine 20 1 1, 5 1 (36): 7-8.

Tian Xian, Wang Haining, Lin and Hong Tianpei (correspondents). Advances in molecular genetics and clinical research of kalman syndrome. Chinese medical journal 20 1 1, 91(30): 2153-265438+.

[39] Liu Ye, Zhang Lin, Hong Tianpei (correspondent) .20 1 1 Summary of research progress and hot spots in the field of diabetes. China Medical Frontier Journal 2011,03 (6): 27-3 1.

Hong Tianpei, a fairy. Pharmacology and pharmacokinetics of basic insulin. Drug evaluation 20 1 1, 08 (15):18-21.

[4 1] Hong Tianpei. Gu Men Ophiopogon japonicus insulin preparation-actively coping with insulin treatment obstacles. Drug evaluation 20 1 1, 08 (2 1): 60-63.

Hong Tianpei. Liraglutide, an analogue of human glucagon-like peptide 1: Advantages of treating type 2 diabetes in China China Diabetes Journal 20 1 1, 19 (3): 238-240.

, Liu Guoqiang, Hong Tianpei, Hou, Gao Meijuan, Lou Jinning, Chen Guian. Changes of MicroRNA expression during the differentiation of human embryonic stem cells into islet-like cells. China Journal of Diabetes 20 10, 18(9):654-659.

Hou, Hong Tianpei (correspondent), Xiao Wenhua, Wang, Wang Haining,. Effect of pioglitazone on biochemical indexes of bone turnover in patients with type 2 diabetes mellitus. China Journal of Diabetes 20 10, 18 (3): 195-65438.

Liu Jinbo, Wang Guang, Hong Tianpei. Study on fenofibrate promoting the re-coupling of nitric oxide synthase in human endothelial cells. Shandong medicine 20 10/0,50 (52):1-3.

Duan, Luo Yong, Hu Maoqing, Wang Li, Bu Ruifang, Hong Tianpei, Xu Yancheng, Zhang Muxun, Liu Junjiang, Bao. Biphasic aspart 30 combined with metformin in the treatment of patients with type 2 diabetes mellitus with poor basal insulin control: efficacy and safety evaluation. China Journal of Endocrinology and Metabolism 20 10.

[47] Gao Meijuan, Hong Tianpei (correspondent), Li. Clinical application prospect of stem cell related therapy technology. China Journal of Diabetes 20 10, 18: 64 1-644. (review)

Wei Rui and Hong Tianpei (correspondents). Research status of autologous bone marrow stem cell transplantation for diabetes mellitus. China Journal of Diabetes 20 10,18 (9): 710-713.

Wei Rui and Hong Tianpei (correspondents). Basic research progress of stem cell therapy for diabetes mellitus. China Journal of Diabetes 20 10/0,2 (6): 474-478.

Lin Yujing, Wang Chen, Hong Tianpei. Application prospect of glucagon-like peptide 1 and its analogues in islet transplantation. China Journal of Diabetes 20 10,18 (10): 728-731. (review)

Hou, Hong Tianpei (correspondent). Effect of incretin on obesity patients with type 2 diabetes treated by bariatric surgery. World chinese journal of digestology 20 10, 18(4):324-328. (review)

Tian Xian, Liu Guoqiang and Hong Tianpei (correspondents). Relationship between subclinical thyroid dysfunction and cardiovascular diseases. International Journal of Endocrinology and Metabolism 20 10/0,30 (supplement): 15- 18.

[53] Tian Xian, Hong Tianpei (correspondent). Blood sugar control goal of patients in intensive care unit: the stricter the better? China Journal of Endocrinology and Metabolism 20 10/0,26 (6): 440-443.

[54] Zhu Dalong, Li Chen and Hong Tianpei (main drafters). Statement of Diabetes Branch of Chinese Medical Association on the treatment of diabetes by stem cell transplantation. China Journal of Diabetes 20 10/0,2 (6): 401-403.

[55] Hong Tianpei. Expert report 2: Basic research progress of stem cell therapy for diabetes mellitus. China Journal of Endocrinology and Metabolism 20 10/0,26 (10):10a-2.

[56] Hong Tianpei, Guo Lixin, Gao Hongwei. Summary of the General Meeting of Endocrinology and Metabolism Branch of Chinese Medical Association and the 20 10 Annual Meeting. China Journal of Diabetes 20 10, 18( 10): Appendix 1-3.

[57] Hong Tianpei, Tian Xian, Du Ying. Summary of research progress and hot spots in the field of 20 10 diabetes treatment. China medical frontier journal 20 10/0,2 (4): 29-33.

Chen Yuanyuan, Song Shujuan, Hong Tianpei (correspondent), Liu Yingzhi, Ren Guocheng, Wen Jinhua, Li. Pathophysiological characteristics of abnormal glucose metabolism in patients with PAX6 gene mutation and iris. China Journal of Diabetes 2009, 17(5):327-330.

Chen Yuanyuan, Hong Tianpei (correspondent), Wen Jinhua, Ding Jun, Gao Xiang, Li Lingsong. Molecular mechanism of abnormal glucose metabolism in Pax6 mutant mice. China Journal of Diabetes 2009, 17(5):335-339.

Zhang Lin, Jin Yang, Hong Tianpei (correspondent), Liu Guoqiang, Wang Chen, Wang Haining. Ghrelin inhibits insulin secretion and upregulates Kir6.2 expression in isolated rat islets. China Journal of Diabetes 2009, 17(5):33 1-334.

[6 1] Xie Chao, Wang Haining, Lin Yujing, Gao Hongwei and Hong Tianpei (correspondents). Effects of nateglinide and acarbose on postprandial serum free fatty acids in patients with type 2 diabetes mellitus. China Journal of Diabetes 2009, 17(5):323-326.

[62] Wang Haining, Li Chen and Hong Tianpei (correspondents). Performance evaluation of Medisafe rapid blood glucose meter. China Journal of Diabetes 2009, 17(3):23 1-234.

[63] Wang Haining, Liu Chen, Su, Hong Tianpei, He. Analysis of image quality and related metabolic factors of myocardial metabolic imaging with fluoride-18 labeled deoxyglucose in patients with type 2 diabetes mellitus. China Journal of Geriatrics 2009,28 (1):165438.

Jin Yang, Liu Guoqiang and Hong Tianpei (correspondents). Therapeutic cloning and somatic cell reprogramming: different paths lead to the same goal. Advances in Physiological Science 2009,40 (2):101-105.

Chen Yuanyuan Hong Tianpei (correspondent). Role of transcription factor Pax6 in islet development and glucose metabolism regulation. International Journal of Endocrinology and Metabolism 2009,29 (3):157-160.

[66] Gao Hongwei and Hong Tianpei (correspondents). Whether the blood sugar control target is as close to normal as possible. Chinese journal of practical internal medicine 2009,29 (3): 205-208.

Hong Tianpei. Pay attention to the significance of the ratio of proinsulin to total insulin in the evaluation of islet β cell function. China Journal of Diabetes 2009, 17(5):32 1-322. (review)

Zhang Lin and Hong Tianpei (correspondents). Inward rectifier potassium channel Kir6.2 and insulin secretion function. China Journal of Diabetes 2009, 17(5):344-347.

Wei Rui, Liu Guoqiang, Hong Tianpei. Clinical application prospect of islet cell regeneration research. Medicine and Philosophy 2009,30 (12):13-16. (Clinical Decision Forum)

[70] Hong Tianpei. Pancreatic β -cell apoptosis in patients with type 2 diabetes mellitus and its intervention strategy. Chinese Journal of Diabetes 2009,1(4): 310-313.

[7 1] Hong Tianpei, Bao. Summary of the First Young Physician Forum of the Youth Committee of Diabetes Branch of Chinese Medical Association. China Journal of Diabetes 2009, 1(6):470-47 1.

[72] Tian Xian, Du Ying and Hong Tianpei (correspondents). Summary of research progress and hot issues in the field of diabetes in 2009. China medical frontier journal 2009,1(2):13-17.